Overview

Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis

Status:
Completed
Trial end date:
2018-02-12
Target enrollment:
Participant gender:
Summary
To collect data on actual-use to assess technical performance and user injections of dupilumab auto-injection device by patients with atopic dermatitis (AD).
Phase:
Phase 1
Details
Lead Sponsor:
Regeneron Pharmaceuticals
Collaborator:
Sanofi